Healthcare & Life Sciences
Ripple Therapeutics
Ripple Therapeutics is a Healthcare & Life Sciences startup based in Canada, most recent round Series A, 1 tracked investor.
Activeseries-a
series-a
Stage
1
Investors
About Ripple Therapeutics
Based in Canada, Ripple Therapeutics is a startup. Its most recent tracked round is Series A. Brouky classifies it under Healthcare & Life Sciences. Brouky records 1 investor associated with the company.
Ripple Therapeutics develops polymer-free, prodrug-based sustained-release implants using its patented Epidel® platform to provide controllable, long-duration delivery of ophthalmic therapeutics for retinal diseases and glaucoma.
Explore Ripple Therapeutics's full profile on Brouky
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.